Skip to main content
Clinical Trials/NCT01560442
NCT01560442
Unknown
Not Applicable

Pupillometry and Pain Thresholds Patients Substituted by Methadone and Buprenorphine.

University Hospital, Clermont-Ferrand1 site in 1 country100 target enrollmentFebruary 2012

Overview

Phase
Not Applicable
Intervention
Buprenorphine and Methadone Hydrochloride
Conditions
Opiate Dependent
Sponsor
University Hospital, Clermont-Ferrand
Enrollment
100
Locations
1
Primary Endpoint
Measurement of the pupil diameter
Last Updated
13 years ago

Overview

Brief Summary

The purpose is to study the relation between pupillary diameter measured under scotopic conditions, and the pain thresholds measured at the time of peak and residual effect of methadone/buprenorphine in opiate-dependent patients following a substitution program.

Detailed Description

Patients substituted since at least 3 months shall be included during a regular control visit. Each session shall consist in * check for toxics in urine sample; * measurement of pupil diameter; * measurement of mechanical punctuate pain threshold; * measurement of mechanical bone pain threshold. A first session shall be done at time of residual effect of the opiate. A second session shall be done at time of peak effect of the opiate.

Registry
clinicaltrials.gov
Start Date
February 2012
End Date
October 2013
Last Updated
13 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Clermont-Ferrand
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • substitution treatment stable since at least 3 months
  • capacity to understand the protocol
  • likely to come to visits
  • covered by French welfare

Exclusion Criteria

  • chronic pain
  • concomitant acute pain
  • pregnancy or breast feeding
  • relevant mental disease
  • peripheral neuropathy
  • regular intake of ketamine
  • neuroleptic concomitant treatment

Arms & Interventions

buprenorphine

Intervention: Buprenorphine and Methadone Hydrochloride

Methadone Hydrochloride

Intervention: Buprenorphine and Methadone Hydrochloride

Outcomes

Primary Outcomes

Measurement of the pupil diameter

Time Frame: 24 hours after the last dose of treatment

Secondary Outcomes

  • - The mechanical punctuate pain threshold as measured by Electronical Von Frey(24 hours after the last dose of treatment, 3 hours after the last dose of methadone and 1 hour ½ after the last dose of buprenorphine)
  • - The mechanical pressure pain threshold measured by Algometer on the tibial bone(24 hours after the last dose of treatment, 3 hours after the last dose of methadone and 1 hour ½ after the last dose of buprenorphine)
  • - The pupil diameter measured in scotopic .conditions (via infrared camera) at the hypothetical peak effect of either methadone or buprenorphine.(24 hours after the last dose of treatment, 3 hours after the last dose of methadone and 1 hour ½ after the last dose of buprenorphine)
  • - The pupil diameter measured in photopic conditions (via infrared camera) at the hypothetical residual effect of either methadone or buprenorphine(24 hours after the last dose of treatment, 3 hours after the last dose of methadone and 1 hour ½ after the last dose of buprenorphine)

Study Sites (1)

Loading locations...

Similar Trials